What are the breast cancer biomarkers?
- BRCA1
- BRCA2
- ATM
- CDH1
- CHEK2
- NBN
- NF1
- PALB2
- PTEN
- STK11
- TP53 (p53)
- Rb
- HER2
- FGFR1/FGFR2/FGFR3
- PIK3CA
- PD-L-1
What is the purpose of genetic testing for breast cancer biomakers?
Gaining information on your breast cancer tumor characteristics at the genetic level may give information that is useful for making treatment decisions; those are sometimes called “biomarkers.” Some clinical trials require the presence or absence of a certain biomarker / genetic alteration. Those trials may require this information in advance of application to the trial, while others may ask for a biopsy of your tumor, and perform the testing on site.
Ready to Own Your Breast Cancer Journey?
- Complete the breast cancer questionnaire.
- Get your list of advanced breast cancer treatment options.
- Compare treatments of patients like you.
- Learn about the treatment or trial that’s right for you.
- Get the guidance you need.
BREAST CANCER COMMUNITY
TrialJectory 2020 Review: A Big Step Towards Cancer Patient Empowerment
2020 has been a difficult year for all of us. At times, we have been completely overwhelmed by the COVID-19 pandemic, but throughout, we have persevered to make a difference
Health Decisions, OncoBay Clinical, and TrialJectory Partner to Provide Specialized Clinical Development Services in Women’s Oncology
Durham, N.C., and Tampa, Fla., December 1, 2020 – Health Decisions, Inc., a full-service contract research organization (CRO) specializing in women’s health clinical research and diagnostic and medical device development,
TIME Selects TrialJectory’s AI-Powered, Clinical Trial-Matching Platform for ‘100 Best Inventions of 2020’ List
Annual List Highlights Groundbreaking Inventions that Change How We Live and Make the World a Better Place NEW YORK, Nov. 20, 2020 — TrialJectory (“the Company”), an AI-powered digital health platform that